5 Key Takeaways

• 1

  Dry eye disease (DED) significantly impacts patients' emotional and mental wellbeing, leading to treatment discontinuation and low compliance.

• 2

  Nine out of ten patients discontinue their initial DED medication within a year, often resulting in frustration and a cycle of ineffective treatments.

• 3

  Untreated DED can become chronic and progressive, causing ocular surface inflammation and negatively affecting patients' daily lives.

• 4

  A personalized approach to DED management, including meaningful patient communication, is essential for improving treatment adherence and satisfaction.

• 5

  Despite the availability of several FDA-approved therapies, less than 10% of diagnosed DED patients receive prescription treatment.